Valuation: DMS

Market Cap 22.66M 25.37M 21.14M 19.2M 36.13M 2.46B 36.48M 254M 99.25M 1.25B 95.26M 93.19M 4.02B P/E 2026 *
29.5x
P/E 2027 * 8.84x
Enterprise Value 38.06M 42.62M 35.5M 32.25M 60.69M 4.13B 61.28M 426M 167M 2.1B 160M 157M 6.75B EV / Sales 2026 *
0.67x
EV / Sales 2027 * 0.47x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-17
Director of Finance/CFO - 2021-12-31
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Chairman 53 2022-07-17
Director/Board Member 52 2025-06-15
Director/Board Member - 2023-07-23
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25.59M
-2.00%-0.79%+20.73%+30.48% 245B
-1.15%+2.11%+5.49%-0.98% 154B
+0.14%+3.44%-7.38%+40.94% 146B
+0.65%-3.81%-57.04%-20.64% 60.26B
-2.47%-1.92%+10.32%+14.62% 49.44B
-0.98%+0.37%+18.81%+50.34% 47.67B
-0.78%+1.73%-21.18%-18.56% 48.04B
+0.68%+0.82%-5.82%+33.34% 45.74B
-1.92%+0.62%+30.67%+60.36% 42.84B
Average -0.72%-1.73%-0.60%+21.10% 93.2B
Weighted average by Cap. -1.00%-2.10%+3.38%+21.94%

Financials

2026 *2027 *
Net sales 56.8M 63.61M 52.99M 48.13M 90.58M 6.16B 91.46M 636M 249M 3.13B 239M 234M 10.07B 65.9M 73.8M 61.48M 55.85M 105M 7.15B 106M 738M 289M 3.63B 277M 271M 11.68B
Net income 800K 896K 746K 678K 1.28M 86.76M 1.29M 8.96M 3.5M 44.09M 3.36M 3.29M 142M 2.6M 2.91M 2.43M 2.2M 4.15M 282M 4.19M 29.12M 11.39M 143M 10.93M 10.69M 461M
Net Debt 15.4M 17.25M 14.37M 13.05M 24.56M 1.67B 24.8M 172M 67.46M 849M 64.75M 63.34M 2.73B 8M 8.96M 7.46M 6.78M 12.76M 868M 12.88M 89.6M 35.05M 441M 33.64M 32.91M 1.42B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - DMS